Summary
In four refractory epileptic patients, peak plasma levels of sodium valproate occurred within 1.5 to 3 h after a single oral dose of valproate and the decline in plasma levels followed a monoexponential course with a t1/2 of 11.4 ± 0.1 h. The mean value for apparent volume of distribution was 0.176 ± 0.013 l/kg and for total plasma clearance 0.0106 ± 0.0009 l/h/kg. Steady state plasma levels were predicted using the method of superposition utilizing pharmacokinetic parameters determined following a single dose of valproate and were 78–123% of the predicted values for two patients receiving valproate alone, and 37–64% of the predicted values for the two patients receiving carbamazepine in addition to valproate. In a further group of 20 patients the mean daily doses of valproate for 8 patients receiving valproate alone (25.4 ± 4.9 mg/kg) was significantly less than those for the 12 patients receiving concomitant anticonvulsant therapy (41.6 ± 12.3 mg/kg) (p<0.005). In addition, the steady state predose plasma levels of valproate were significantly higher in the valproate alone patients (90.3 ± 8.7 µg/ml) compared to the patients receiving additional anticonvulsants (75.3 ± 13.8 µg/ml) (p<0.01). The higher dose requirements of valproate and lower predose and steady state plasma levels for those patients on multiple anticonvulsants indicate an interaction between valproate and other anticonvulsants.
Similar content being viewed by others
References
Gibaldi, M. and Perrier, D.: Pharmacokinetics. In: Drugs and the pharmaceutical sciences, Vol. 1, J. Swarbrick (ed). New York: Marcel Dekker, 1975
Gugler, R., Schell, A., Eichelbaum, M., Froscher, W., Schulz, H. U.: Disposition of valproic acid in man. Eur. J. Clin. Pharmacol.12, 125–132 (1977)
Klotz, U., Antonin, K. H.: Pharmacokinetics and bioavailability of sodium valproate. Clin. Pharmacol. Ther.21, 736–743 (1977)
Loisseau, P., Brachet, A., Henry, P.: Concentration of dipropylacetate in plasma. Epilepsia16, 609–615 (1975)
Meinardi, H.: Clinical trials of antiepileptic drugs. Psychiatr. Neurol. Neurochir.74, 141–151 (1971)
Meunier, G., Carraz, G., Meunier, U., Eymard, P., Aimard, M.: Properties pharmacodynamiques de l'acide n-dipropylacetique. Therapie18, 435–438 (1963)
Monks, A., Boobis, S., Wadsworth, J., Richens, A.: Plasma protein binding interaction between phenytoin and valproic acid in vitro. Br. J. Clin. Pharmacol.6, 487–492 (1978)
Perucca, E., Gatti, G., Frigo, G. M., Crema, A.: Pharmacokinetics of valproic acid after oral and intravenous administration. Br. J. Clin. Pharmacol.5, 313–318 (1978a)
Perucca, E., Gatti, G., Frigo, G. M., Crema, A., Calzetti, S., Visintini, D.: Disposition of sodium valproate in epileptic patients. Br. J. Clin. Pharmacol.5, 495–499 (1978b)
Pinder, R. M., Brodgen, R. N., Speight, T. M., Avery, G. S.: Sodium valproate: A review of its pharmacological properties and therapeutic efficacy in epilepsy. Drugs13, 81–123 (1977)
Richens, A., Ahmad, S.: Controlled trial of sodium valproate in severe epilepsy. Br. Med. J.1975/IV, 255–256
Richens, A., Scoular, I. T., Ahmad, S., Jordan, B. J.: Pharmacokinetics and efficacy of epilim in patients receiving long-term therapy with other antiepileptic drugs. In: Clinical and pharmacological aspects of sodium valproate (Epilim) in the treatment of epilepsy. N. J. Legg, (ed.) pp. 78–88. Turnbridge: MCS Consultants 1976
Simon, D., Penry, J. K.: Sodium Di-N-propylacetate (DPA) in the treatment of epilepsy — a review. Epilepsia16, 549–573 (1975)
Suzuki, M., Maruyama, H., Ishibashi, Y., Ogawa, S., Seki, T., Hoshino, M., Maekawa, J., Yo, T., Sato, Y.: A double blind comparative trial of sodium dipropylacetate and ethosuximide in epilepsy in children, with special emphasis on pure petit mal seizures (In Japanese) Med. Prog.. (Japan)82, 470–488 (1972)
Vajda, F., Drummer, O., Morris, P., McNeil, J., Bladin, P.: Gas chromatographic measurement of plasma levels of sodium valproate: Tentative therapeutic range of a new anticonvulsant in the treatment of refractory epileptics. Clin. Exp. Pharmacol. Physiol.5, 67–73 (1978a)
Vajda, F., Mihaly, G., Miles, J., Morris, P., Bladin, P.: Sodium valproate: Dose-plasma level relationships and interdose fluctuations. Clin. Exp. Neurol. (in press 1978b)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mihaly, G.W., Vajda, F.J., Miles, J.L. et al. Single and chronic dose pharmacokinetic studies of sodium valproate in epileptic patients. Eur J Clin Pharmacol 16, 23–29 (1979). https://doi.org/10.1007/BF00644962
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00644962